½ÃÀ庸°í¼­
»óǰÄÚµå
1686589

¸¶Ãë ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)

Anesthesia Monitoring Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Mordor Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸¶Ãë ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 29¾ï ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ÀÎ 2025-2030³â CAGR 10.02%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 46¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Anesthesia Monitoring Devices-Market-IMG1

COVID-19ÀÇ À¯ÇàÀº ÇコÄÉ¾î ºÎ¹®¿¡ ¿µÇâÀ» ¹ÌÃÆ°í, À¯ÇàÀÇ Ã¹ ´Ü°è¿¡¼­´Â Á¤ºÎ¿¡ ÀÇÇÑ »çȸÀû °Å¸®¸¦ µÎ´Â Á¶Ä¡·Î º´¿ø°ú ÇコÄÉ¾î ¼­ºñ½º°¡ Å©°Ô Ãà¼ÒµÇ¾ú½À´Ï´Ù. °Ô´Ù°¡ COVID-19ÀÇ À¯ÇàÀº °æÁ¦¿¡ ¿µÇâÀ» ÁÖ¾ú°í, º´¿ø¿¡¼­ COVID-19 ÀÌ¿ÜÀÇ È¯ÀÚ¿¡ ´ëÇÑ ÀÏ¹Ý º´¿øÀÇ Áø·á ±â´É¿¡µµ ¾Ç¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 9¿ù¿¡ Journal of Anaesthesia¿¡ °ÔÀçµÈ ³í¹®¿¡ µû¸£¸é, ¸¶Ãë ½ºÅÂÇÁÀÇ 3ºÐÀÇ 1ÀÌ ºÎÀçÇϰí, ¼ö¼ú½ÇÀÇ 42%°¡ Æó¼âµÇ¾î, ÆÒµ¥¹Í ½Ã Á¦ÇÑÀ¸·Î ¾Ï ¼ö¼ú ¹× ±ä±Þ ¼ö¼úÀÌ °¨¼ÒÇÏ´Â µî Àü±¹ÀûÀÎ ¼ö¼ú Ȱµ¿Àº Àý¹Ý ÀÌÇÏ·Î °¨¼ÒÇß½À´Ï´Ù. ±×·¯³ª ÆÒµ¥¹Í 2´Ü°è·Î Á¢¾îµéÀÚ Á¦ÇÑÀ¸·Î ÀÎÇØ Áö¿¬µÈ ¼ö¼úÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿Í ÇÔ²² COVID-19 °¨¿° ȯÀÚ¿¡ ´ëÇÑ ÁßÁõ Ä¡·á ÀåºñÀÇ Çʿ伺À¸·Î ¸¶Ãë ¸ð´ÏÅ͸µ ±â±â ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù. ¿¹¸¦ µé¾î, Economic Times º¸µµ ÀÚ·á¿¡ µû¸£¸é, 2022³â 7¿ù, ¹Î°£ º´¿ø ¹× Ŭ¸®´Ð¿¡¼­´Â ÆÒµ¥¹Í ÀÌÀü¿¡ ºñÇØ ¼±ÅÃÀû ¼ö¼úÀÌ 20-30% Áõ°¡Çϰí Áö³­ 2³â°£ COVID °¨¿°¿¡ ´ëÇÑ ¿ì·Á·Î ¼ö¼úÀ» ¿¬±âÇϰųª °ÅºÎÇß´ø ȯÀÚ°¡ ±× ¼ö¼úÀ» ¹Þ±â À§ÇØ ÁÙÀ» ¼¹½À´Ï´Ù. µû¶ó¼­ COVID-19 ÆÒµ¥¹ÍÀº Ãʱ⠴ܰ迡¼­´Â ½ÃÀå ¼ºÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆÁö¸¸ ¼ö¼ú Àç°³·Î ȸº¹Çϱ⠽ÃÀÛÇß½À´Ï´Ù.

½ÃÀå ¹ßÀüÀÇ ¿äÀÎÀ¸·Î´Â ¸¶Ãë ±â¼ú ¹× ÀÚµ¿ ±â·Ï ½Ã½ºÅÛÀÇ °³¹ß, ¹«Åë¼ö¼ú ¼ö¿ä Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 11¿ù¿¡ Acta Anaesthesiologica Scandinavica°¡ ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é, ¿ÀÇÇ¿ÀÀ̵带 »ç¿ëÇÏÁö ¾Ê´Â ¸¶Ãë´Â ȯÀÚÀÇ ¾ÈÀü¼º ¹× ÅëÁõ °ü¸®¿¡ ¾Ç¿µÇâÀ» ¹ÌÄ¡´Â Áõ°Å ¾øÀÌ ÀϺΠ¼ö¼ú ȯ°æ¿¡¼­ ¼ö¼ú ÈÄ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡Àº ¹«Åë ¼ö¼ú ¼ö¿ä¸¦ Áõ°¡½ÃŰ°í ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°Ô´Ù°¡ ½ÃÀå ÁøÃâ ±â¾÷¿¡ ÀÇÇÑ ÀÌ´Ï¼ÅÆ¼ºê, Á¦Ç° Ãâ½Ã ¹× Àü·« Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¸é, 2021³â 11¿ù, MDoloris Medical Systems´Â °íÁÖÆÄ º¯µ¿Áö¼ö ¸ð´ÏÅÍ HFVI MOC-9ÀÇ ÀϺ»¿¡¼­ÀÇ ¾à»ç ½ÂÀÎÀ» ÃëµæÇß½À´Ï´Ù. HFVI MOC-9 ±â¼úÀº ÁøÅë ¸¶Ã븦 ¹Þ´Â ȯÀÚ¸¦ À§ÇÑ Ã¹ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÔ´Ï´Ù.

µû¶ó¼­ À§ÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¸¶Ãë ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ±âÁ¸ ±â¼úÀÇ °¡¿ë¼º ¹× ¸¶Ãë ¸ð´ÏÅ͸µ ±â±âÀÇ °íºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸¶Ãë ¸ð´ÏÅ͸µ ±â±â ½ÃÀå µ¿Çâ

MRI ´ëÀÀ ¸¶Ãë ¸ð´ÏÅÍ´Â ¿¹Ãø ±â°£ µ¿¾È ²ÙÁØÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

Àڱ⠰ø¸í ¿µ»ó(MRI)¿¡¼­ ¸¶Ãë ¶Ç´Â MRI ÁöħÀ» ÇÊ¿ä·Î ÇÏ´Â ¼ö¼úÀ» ¼öÇàÇÒ ¶§ ¸¶Ãë´Â ÀÌ °Ë»ç ¾ç½ÄÀÇ Àû¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¸¶ÃëÀÇ¿¡°Ô ´õ ºó¹øÇÏ°í º¹ÀâÇÑ Ä¡·á°¡ µÇ°í ÀÖ½À´Ï´Ù. ¾Ï µî ¸¸¼ºÁúȯ Áõ°¡·Î ÀÎÇÑ MRI ¼ö¿ä Áõ°¡°¡ ºÎ¹® ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, RadioGraphics°¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é, 2021³â 2¿ù, ȯÀÚ, ÀÇ·á Á¦°ø¾÷ü, ¹æ»ç¼±°ú Àǻ簡 ÀÌ ¾ç½ÄÀÇ ÀÓ»óÀû ¿ëµµ¿¡ ´ëÇÑ ÀÌÇØ¸¦ ±í°Ô ÇÏ´Â °ÍÀ» ¹è°æÀ¸·Î MRI ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù. °Ô´Ù°¡ ¹ü¹Ì º¸°Ç±â±¸(Pan American Health Organization)°¡ 2023³â¿¡ ¹ßÇ¥ÇÑ ÃֽŠÁ¤º¸¿¡ µû¸£¸é ¼¼°è¿¡¼­ »õ·Ó°Ô ¹ß»ýÇÏ´Â ¾Ï ȯÀÚ¼ö´Â 2,000¸¸ ¸íÀ¸·Î ÃßÁ¤µÇ¸ç, ÇâÈÄ 20³â°£ ¾Ï ºÎ´ãÀº ¾à 60% Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶Ç, ¿¹ÃøµÇ´Â ¼¼°èÀÇ ºÎ´ãÀº 2040³â±îÁö »õ·Ó°Ô ¹ß»ýÇÏ´Â ¾Ï Áõ·Ê°¡ ¾à 3,000¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °¡´É¼ºÀÌ ³ô°í, °¡Àå Áõ°¡ÇÏ´Â °ÍÀº ÁßÀú¼Òµæ±¹À̶ó°í Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ¾Ï ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó MRI ¼ö¿ä°¡ Áõ°¡ÇÏ°í ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°Ô´Ù°¡ ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ Á¦Ç° ÅõÀÔÀ̳ª Àü·« µîÀÇ ´ëó°¡ Ȱ¹ßÇØÁö°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î SCHILLER´Â 2022³â 4¿ù¿¡ MRI ´ëÀÀ ȯÀÚ ¸ð´ÏÅÍ 'MAGLIFE RT-1'À» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ¸ð´ÏÅÍ´Â °Ë»ç Áß ±ä¹ÐÇÑ ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô Çϸç, 'MAGSCREEN RT-1'À» ÅëÇØ ÆÐ·¯µ¥ÀÌ ÄÉÀÌÁö ¿ÜºÎ¿¡¼­ ¿ÏÀüÈ÷ Á¦¾îÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¼ºÀÎ, ¼Ò¾Æ, ½Å»ý¾Æ¸¦ Æ÷ÇÔÇÑ ¸ðµç ȯÀÚ¸¦ ´ë»óÀ¸·Î ¼³°èµÇ¾ú½À´Ï´Ù.

µû¶ó¼­, »ó±â ¿äÀÎÀÌ ¿¹Ãø ±â°£ µ¿¾È ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå Á¡À¯À²ÀÌ Å©°Ô ´Ã¾î³¯ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì¿¡¼­´Â ºñ¸¸, ½ÉÇ÷°ü Áúȯ, °¢Á¾ ¾Ï µîÀÇ Áúº´ÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ¿© ¼ö¼ú °Ç¼ö Áõ°¡¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¸¼ºÁúȯ ¼ö¼ú °Ç¼ö Áõ°¡°¡ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î Cedars-Sinai°¡ 2022³â 1¿ù °»½ÅÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¿ìȸ¼ö¼ú·Îµµ ¾Ë·ÁÁø °ü»óµ¿¸Æ¿ìȸÀ̽ļö¼ú(CABG)Àº °¡Àå ÀϹÝÀûÀÎ ½ÉÀå¼ö¼ú·Î ¹Ì±¹¿¡¼­´Â ¸Å³â 30¸¸ ¸í ÀÌ»óÀÌ ¿ìȸ¼ö¼úÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶Ç, ¹Ì±¹ Áúº´ ¿¹¹æ °ü¸® ¼¾ÅÍ(CDC)°¡ 2022³â 10¿ù¿¡ °»½ÅÇÑ µ¥ÀÌÅÍ¿¡ ÀÇÇϸé, 40ÃÊ¿¡ 1¸íÀÌ ½ÉÀå ¹ßÀÛÀ» ÀÏÀ¸Å°°í, ¹Ì±¹¿¡¼­´Â ¸Å³â 80¸¸ 5,000¸í °¡±îÀ̰¡ ½ÉÀå ¹ßÀÛÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌó·³ ¸¸¼ºÁúȯÀ¸·Î ÀÎÇÑ ¼ö¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¸¶Ãë ¸ð´ÏÅ͸µ ±â±âÀÇ ¼ö¿ä´Â Áõ°¡Çϰí, ÀÌ·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ ÃËÁøµÉ ¼ö ÀÖ½À´Ï´Ù.

°Ô´Ù°¡ ºÏ¹Ì¿¡¼­ÀÇ ºó¹øÇÑ ½ÂÀΰú Ãâ½Ãµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 2¿ù, ¸¶½Ã¸ð´Â ¹Ì±¹¿¡¼­ 1¼¼ ȯÀÚ¿¡°Ô »ç¿ëÇÒ ¼ö ÀÖ´Â SedLineÀÇ °íµµ¸¶Ãë ½Éµµ ¸ð´ÏÅ͸µ FDA Àΰ¡¸¦ ȹµæÇß½À´Ï´Ù.

µû¶ó¼­ ÀÌ Áö¿ªÀº À§ÀÇ ¿äÀο¡ ÀÇÇØ ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸¶Ãë ¸ð´ÏÅ͸µ ±â±â »ê¾÷ °³¿ä

¸¶Ãë ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¼¼°è ¹× Áö¿ªÀûÀ¸·Î »ç¾÷À» Àü°³ÇÏ´Â ±â¾÷ÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ ±× ¼º°Ý»ó Àû´çÈ÷ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. °æÇÕ Á¤¼¼¿¡´Â ½ÃÀå Á¡À¯À²À» °¡Áö°í Áö¸íµµ°¡ ³ôÀº ±¹Á¦ ±â¾÷À̳ª ÇöÁö ±â¾÷ÀÇ ºÐ¼®ÀÌ Æ÷ÇԵǾî ÀÖÀ¸¸ç Dragerwerk AG & Co.KGaA, Masimo, Mindray Medical International Limited, Medtronic Plc., GE Healthcare µîÀÌ ÀÖ½À´Ï´Ù.

±âŸ ÇýÅÃ

  • ¿¢¼¿ Çü½Ä ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
  • 3°³¿ù°£ÀÇ ¾Ö³Î¸®½ºÆ® ¼­Æ÷Æ®

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç ¹× ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå °³¿ä
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¶Ãë ±â¼ú ¹× ÀÚµ¿ ±â·Ï ½Ã½ºÅÛ °³¹ß
    • ¹«Åë ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¾·¡ ±â¼ú °¡¿ë¼º ¹× ¸¶Ãë ¸ð´ÏÅ͸µ ±â±âÀÇ °íºñ¿ë
  • Porter's Five Forces ºÐ¼®
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ±¸¸ÅÀÚ ¹× ¼ÒºñÀÚÀÇ Çù»ó·Â
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°èÀÇ °­µµ

Á¦5Àå ½ÃÀå ¼¼ºÐÈ­

  • Á¦Ç°º°
    • ±âº» ¸¶Ãë ¸ð´ÏÅÍ
    • ÅëÇÕ ¸¶Ãë ¿öÅ©½ºÅ×À̼Ç
    • °íµµ ¸¶Ãë ¸ð´ÏÅÍ
      • °¡½º ¸ð´ÏÅÍ
      • µ¶¸³Çü Ä«ÇÁ³ë±×·¡ÇÇ ¸ð´ÏÅÍ
      • ¸¶Ãë ±íÀÌ ¸ð´ÏÅÍ
      • MRI ´ëÀÀ ¸¶Ãë ¸ð´ÏÅÍ
    • ±âŸ
  • ÃÖÁ¾ »ç¿ëÀÚº°
    • º´¿ø
    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Áö¿ªº°
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
    • À¯·´
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
      • GCC
      • ³²¾ÆÇÁ¸®Ä«
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¹Ì
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ³²¹Ì

Á¦6Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Medtronic PLC
    • Masimo Corporation
    • Nihon Kohden Corporation
    • GE Healthcare
    • Koninklijke Philips NV
    • Dragerwerk AG & Co. KGaA
    • Mindray Medical International Limited
    • Infinium Medical
    • Schiller AG
    • Getinge Inc.

Á¦7Àå ½ÃÀå ±âȸ ¹× ÇâÈÄ µ¿Çâ

AJY

The Anesthesia Monitoring Devices Market size is estimated at USD 2.90 billion in 2025, and is expected to reach USD 4.68 billion by 2030, at a CAGR of 10.02% during the forecast period (2025-2030).

Anesthesia Monitoring Devices - Market - IMG1

The COVID-19 outbreak impacted the healthcare sector, as hospital and healthcare services were significantly reduced in the first phase of the pandemic due to social distancing measures taken by the government. Moreover, the COVID-19 pandemic affected the economy and adversely impacted the functioning of general hospital care for non-COVID-19 patients in hospitals. For instance, an article published in the Journal of Anaesthesia in September 2021, one-third of the anesthesia staff were unavailable, 42% of operating theaters were closed, and national surgical activity was reduced to less than half, including reduced cancer and emergency surgery due to the restriction imposed during the pandemic. However, in the second phase of the pandemic, there was an increased demand for anesthesia monitoring devices due to the need for critical care equipment for patients infected with COVID-19 infection, along with patients who needed surgeries that got delayed due to the restriction. For instance, according to a press release by the Economic Times, in July 2022, private hospitals and clinics across the board saw a 20%-30% increase in elective procedures compared with pre-pandemic levels, patients who had postponed or refused surgery due to concerns about COVID infections in the last two years were lining up to have those procedures done. Hence, the COVID-19 pandemic had significantly impacted the market growth during the initial phases but as the started to recover due to the resumption in the surgeries.

Certain factors driving the market growth include development in anesthesia technology and automated record-keeping systems, and an increase in the demand for pain-free surgeries. For instance, according to an article published by Acta Anaesthesiologica Scandinavica in November 2021, opioid-free anesthesia can improve postoperative outcomes in several surgical settings without evidence of adverse effects on patient safety and pain management. Such an advantage is expected to increase the demand for pain-free surgeries, driving market growth over the forecast period.

Additionally, the increasing initiatives, product launches, and strategies by market players are also expected to contribute to the market growth. For instance, in November 2021, MDoloris Medical Systems secured regulatory clearance for its HFVI MOC-9 high-frequency variability index monitor in Japan. The HFVI MOC-9 technology is the first monitoring solution for patients undergoing analgosedation and anesthesia.

Hence, due to the abovementioned factors, the anesthesia monitoring device market is anticipated to grow over the forecast period. However, the availability of conventional techniques and the high cost of anesthesia monitoring devices will likely restrain the market growth.

Anesthesia Monitoring Devices Market Trends

MRI Compatible Anesthesia Monitor is Expected to Witness Steady Growth Over the Forecast Period

Anesthesia in magnetic resonance imaging (MRI), or when performing surgery that requires MRI guidance is becoming a more frequent and complex procedure for anesthetists as the study modality is increasing in the application. An increase in the demand for MRI due to the rise in chronic diseases such as cancer is expected to drive segmental growth. For instance, according to an article published by RadioGraphics, in February 2021, demand for MRI increased, driven by patients', providers', and radiologists' evolving understanding of clinical uses for the modality. Furthermore, according to the Pan American Health Organization update in 2023, there were an estimated 20 million new cancer cases globally and the cancer burden is likely to increase by approximately 60% over the next two decades. It also stated that the predicted global burden is likely to increase to about 30 million new cancer cases by 2040, with the greatest increases occurring in low- and middle-income countries. Therefore, with a rise in cancer cases, the demand for MRI is projected to increase thereby contributing to the market growth.

Additionally, the increasing initiatives, such as product launches and strategies by market players are expected to contribute to the market growth. For instance, in April 2022, SCHILLER launched the MRI-compatible patient monitor MAGLIFE RT-1 which allows for close monitoring during the examination and can be fully controlled from outside the Faraday cage via the MAGSCREEN RT-1. The system is designed for all patients, including adults, children, and neonates.

Hence, the abovementioned factors are expected to drive segment growth over the forecast period.

North America is Expected to Show a Significant Growth in Market Share During the Forecast Period

North America is anticipated to observe a continual increase in diseases, like obesity, cardiovascular problems, and various types of cancers, contributing to the rise in surgeries. The increase in the number of surgeries for chronic diseases has helped expand the anesthesia monitoring devices market. For instance, the data updated by Cedars-Sinai in January 2022 shows that coronary artery bypass graft surgery (CABG), also known as bypass surgery, is the most common heart surgery, and more than 300,000 people have successful bypass surgery in the United States each year. In addition, per the data updated by the Centers for Disease Control and Prevention (CDC) in October 2022, every 40 seconds, someone suffers from a heart attack, and nearly 805,000 people in the United States have a heart attack every year. Thus, with an increase in surgeries due to chronic diseases, the demand for anesthesia monitoring devices is likely to increase thereby driving market growth.

Moreover, frequent approvals and launches in North America are also expected to drive market growth. For instance, in February 2022, Masimo received FDA clearance for SedLine's advanced depth of anesthesia monitoring for use on patients as young as 1 year old in the United States.

Hence, the region is anticipated to witness growth during the forecast period due to the abovementioned factors.

Anesthesia Monitoring Devices Industry Overview

The anesthesia monitoring devices market is moderately concentrated in nature due to the presence of companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including Dragerwerk AG & Co. KGaA, Masimo, Mindray Medical International Limited, Medtronic Plc., and GE Healthcare, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Development in Anesthesia Technology and Automated Record-keeping Systems
    • 4.2.2 Increase in the Demand for Pain-free Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Availability of Conventional Techniques and High Cost of Anesthesia Monitoring Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Basic Anesthesia Monitor
    • 5.1.2 Integrated Anesthesia Workstation
    • 5.1.3 Advanced Anesthesia Monitor
      • 5.1.3.1 Gas Monitor
      • 5.1.3.2 Standalone Capnography Monitor
      • 5.1.3.3 Monitors for Depth of Anesthesia
      • 5.1.3.4 MRI Compatible Anesthesia Monitor
    • 5.1.4 Other Products
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgery Centers
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic PLC
    • 6.1.2 Masimo Corporation
    • 6.1.3 Nihon Kohden Corporation
    • 6.1.4 GE Healthcare
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 Dragerwerk AG & Co. KGaA
    • 6.1.7 Mindray Medical International Limited
    • 6.1.8 Infinium Medical
    • 6.1.9 Schiller AG
    • 6.1.10 Getinge Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦